Keryx Biopharma (KERX) Misses Q3 EPS by 19c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Tech stocks pull Wall Street lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Keryx Biopharma (KERX) Files $250M Mixed Securities Shelf
November 9, 2016 7:29 AM ESTKeryx Biopharma (NASDAQ: KERX) filed a registration with the U.S. SEC to sell up to $250 million of mixed securities.
... More